Developer of long-read DNA sequencing technology for precision medicine. The technology used is a nanopore-based sequencing technique for enabling the detection of genome variations. It enables clinicians to provide precision medicine. The company was founded in 2015 and headquartered in Albuquerque, United States. It has raised $7.7M in series b funding, with backing from NHGRI, BFA, Cottonwood Technology Fund, Tramway Venture Partners, and others. The company operates in the Life Sciences - Genomics, Life Sciences - Clinical Genomics space. Within the Life Sciences - Genomics and Life Sciences - Clinical Genomics landscape, the company aims to address evolving market needs through its specialized approach.
← All startups
Armonica Technologies
Series BDeveloper of long-read DNA sequencing technology for precision medicine. The technology used is a nanopore-based sequencing technique for enabling the detection of genome variations. It enables clinicians to provide precision medicine. The company was founded in 2015 and headquartered in Albuquerque, United States. It has raised $7.7M in series b funding, with backing from NHGRI, BFA, Cottonwood Technology Fund,…
About
Business model
Genomics > Applied Genomics > Clinical Genomics > Diagnostics > Sequencing-based > Precision Medicine
Institutional investors
NHGRIBFACottonwood Technology FundTramway Venture PartnersSun Mountain CapitalHamamatsu PhotonicsHHSNM Vintage Fund
Latest coverage
📰 See all funding news — keep up with the raises that set comps.
Investor directory
🗂️ Browse all funds in our directory — active VCs and growth investors by stage and sector.
Similar startups
Raising like Armonica Technologies?
Analyze your pitch deck before your next raise.
Analyze My Deck →